PHARMACOECONOMIC ANALYSIS OF UROTHELIAL TRANSITIONAL CELL CANCER TREATMENT WITH VINFLUNINE IN PATIENTS RESISTANT TO THE PLATINUM-BASED TREATMENT REGIMES

被引：0
|
作者：
Yagudina, R. [1 ]
Kulikov, A. [1 ]
Rybchenko, Y. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1097
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN81
引用
收藏
页码：A443 / A444
页数：2
相关论文
共 50 条
  • [21] The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
    Ak, Guntulu
    Metintas, Selma
    Akarsu, Muhittin
    Metintas, Muzaffer
    BMC CANCER, 2015, 15
  • [22] The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
    Guntulu Ak
    Selma Metintas
    Muhittin Akarsu
    Muzaffer Metintas
    BMC Cancer, 15
  • [23] Vinflunine - an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study
    Bennouna, J.
    Breton, J. -L.
    Tourani, J. -M.
    Ottensmeier, C.
    O'Brien, M.
    Kosmidis, P.
    Huat, T. E.
    Pinel, M. -C.
    Colin, C.
    Douillard, J. -Y
    BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1383 - 1388
  • [24] Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study
    J Bennouna
    J-L Breton
    J-M Tourani
    C Ottensmeier
    M O'Brien
    P Kosmidis
    T E Huat
    M-C Pinel
    C Colin
    J-Y Douillard
    British Journal of Cancer, 2006, 94 : 1383 - 1388
  • [25] BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT
    Davidenko, I.
    Kazantseva, M.
    Porhanova, N.
    Potemin, S.
    Oganyan, M.
    Syrota, L.
    Shmatkova, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [26] Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment
    Heddens, D
    Alberts, DS
    Hannigan, EV
    Williams, SD
    Garcia, D
    Roe, DJ
    Bell, J
    Alvarez, RD
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 239 - 243
  • [27] The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy
    Kastritis, Efstathios
    Dimopoulos, Meletios-Athanasios
    Antoniou, Nikolaos
    Deliveliotis, Charalambos
    Chrisofos, Michael
    Skolarikos, Andreas
    Gika, Dimitra
    Bamias, Aristotle
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3865 - 3869
  • [28] Management of urothelial cancer in patients with chronic kidney disease receiving platinum-based chemotherapy
    O'Dwyer, Richard
    Jiang, Di Maria
    Kitchlu, Abhijat
    Coulombe, Antoine Morin
    Sridhar, Srikala S.
    FUTURE ONCOLOGY, 2024, 20 (36) : 2889 - 2899
  • [29] Outcome of elderly patients following platinum-based chemotherapy for advanced urothelial cancer.
    Barnias, A
    Efstathiou, E
    Hamilos, G
    Zorzou, P
    Bozas, G
    Gika, D
    Papadimitriou, C
    Dimopoulos, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 392S - 392S
  • [30] Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy
    Largillier, R.
    Valenza, B.
    Ferrero, J. -M.
    Novo, C.
    Creisson, A.
    Lesbats, G.
    Mari, V.
    Hebert, C.
    Chamorey, E.
    ONCOLOGY, 2007, 73 (3-4) : 177 - 184
12345